Overview

A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood

Status:
Recruiting
Trial end date:
2021-12-22
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to investigate the effect of fluconazole, under steady state conditions on the pharmacokinetics of BI 425809 (Reference Treatment R: BI 425809 alone; Test Treatment T: BI 425809 given under steady state conditions of fluconazole).
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
BI 425809
Fluconazole